House and Senate lawmakers reintroduced the Creates Act, a controversial bill aimed at curbing tactics brand-name drugmakers use to stymie generic and biosimilar competition.
Lawmakers revive Creates Act opposed by Big Pharma
House and Senate lawmakers reintroduced the Creates Act, a controversial bill aimed at curbing tactics brand-name drugmakers use to stymie generic and biosimilar competition.